SEC 13F Intelligence

Sg Americas Securities, LLC / ABBV

Sg Americas Securities, LLC’s Abbvie Inc Position

Does Sg Americas Securities, LLC own Abbvie Inc (ABBV)? Yes1.14M shares worth $247M (+0.27% of its 13F portfolio) as of Q1 2026, up from 522.6K shares the prior filed quarter.

Position Value
$247M
Q1 2026
Shares
1.14M
% of Portfolio
+0.27%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $26MQ4 ’18Q1 ’19: $13MQ2 ’19: $29MQ3 ’19: $537,000Q4 ’19: $8MQ4 ’19Q1 ’20: $8MQ2 ’20: $11MQ3 ’20: $7MQ4 ’20: $23MQ4 ’20Q1 ’21: $19MQ2 ’21: $37MQ3 ’21: $17MQ4 ’21: $57MQ4 ’21Q1 ’22: $32MQ2 ’22: $41MQ3 ’22: $40MQ4 ’22: $5MQ4 ’22Q1 ’23: $35MQ2 ’23: $56MQ3 ’23: $36MQ4 ’23: $124MQ4 ’23Q1 ’24: $90MQ2 ’24: $42MQ3 ’24: $5MQ4 ’24: $17MQ4 ’24Q1 ’25: $23MQ2 ’25: $79MQ3 ’25: $61MQ4 ’25: $119MQ4 ’25Q1 ’26: $247Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.14M$247M+0.27%
Q4 2025522.6K$119M+0.15%
Q3 2025262.9K$61M+0.21%
Q2 2025428.3K$79M+0.33%
Q1 2025111.4K$23M+0.08%
Q4 202498.0K$17M+0.07%
Q3 202424.4K$5M+0.02%
Q2 2024244.6K$42M+0.24%
Q1 2024492.1K$90M+0.43%
Q4 2023797.3K$124M+1.15%
Q3 2023242.9K$36M+0.41%
Q2 2023414.4K$56M+0.42%
Q1 2023219.9K$35M+0.41%
Q4 202233.7K$5M+0.07%
Q3 2022294.5K$40M+0.49%
Q2 2022268.3K$41M+0.44%
Q1 2022199.9K$32M+0.24%
Q4 2021422.5K$57M+0.31%
Q3 2021157.2K$17M+0.08%
Q2 2021325.1K$37M+0.17%
Q1 2021173.1K$19M+0.10%
Q4 2020215.3K$23M+0.12%
Q3 202077.0K$7M+0.04%
Q2 2020110.6K$11M+0.09%
Q1 2020109.0K$8M+0.08%
Q4 201995.7K$8M+0.08%
Q3 20197.1K$537,0000.00%
Q2 2019398.9K$29M+0.20%
Q1 2019165.9K$13M+0.12%
Q4 2018284.0K$26M+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sg Americas Securities, LLC’s full portfolio or all institutional holders of ABBV.